Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, August 18, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8899 POSTS
0 Comments
https://bostonlifesciencestimes.com
Public Health
Global Covid-19 cases surpass 74.8 million: Johns Hopkins
Life Sciences Times
-
December 18, 2020
0
Public Health
New study strongly suggests Covid-19 enters brain
Life Sciences Times
-
December 18, 2020
0
Pharma
India to produce 300 million doses of the Russian Sputnik V vaccine in 2021: Report
Life Sciences Times
-
December 18, 2020
0
Public Health
Study reveals why women face less severe Covid-19 complications
Life Sciences Times
-
December 18, 2020
0
Public Health
Higher intake of ultra-processed foods may up death risk
Life Sciences Times
-
December 18, 2020
0
Venture Capital
Cirtec Medical Announces Acquisition of NovelCath
Life Sciences Times
-
December 17, 2020
0
Venture Capital
Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms
Life Sciences Times
-
December 17, 2020
0
Venture Capital
ECS Awarded $28.8 Million USMC IT Service and Support Contract
Life Sciences Times
-
December 17, 2020
0
Medtech
Cedar Gate Technologies Acquires Lexington-Based Deerwalk
Life Sciences Times
-
December 17, 2020
0
Biotech
Ginkgo Bioworks Acquires Biotechnology Startup Novogy
Life Sciences Times
-
December 17, 2020
0
1
...
882
883
884
...
890
Page 883 of 890
TOP AUTHORS
Life Sciences Times
8899 POSTS
0 Comments
https://bostonlifesciencestimes.com
Most Read
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
August 18, 2026
Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer
August 18, 2026
Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline
August 18, 2026
Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs
August 18, 2026